It increases the risk of: Type 2 diabetes MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD) Cardiovascular disease The loss of estrogen also accelerates sarcopenia, the loss of lean muscle mass, which further slows metabolism and reduces energy expenditure
M., Fayez, A
doi: 10.1136/ard.2004.034777 113 PietrzakAMichalak-StomaAChodorowskaGSzepietowskiJC
Discovery of investigational drug CT1812, an antagonist of the Sigma-2 receptor complex for Alzheimers disease
Xu C, Sun L, Ren F, Huang P, Tian Z, Cui J, et al
However, clinical evidence supporting Lipo C as a standalone weight loss intervention remains limited compared to pharmaceutical-grade medications